News

FDA approves powerful HIV drug with the potential to end the epidemic in the U.S.
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list
A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...
FDA offers speedier approvals to drug companies aligning with 'national priorities'
On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an ...
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding ...
Kraft Heinz, General Mills to remove artificial dyes from food products over next 2 years
Kraft Heinz and General Mills announced on Tuesday that they would be removing artificial food dyes from their products ...
FDA announces sweeping changes to speed up the drug review process
An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...
New FDA Chief Wants to Fast-Track Some Drugs, Use More AI
FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.
STAT23h
FDA announces a new priority review program in bid to further administration goals
The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...
STAT5h
Vinay Prasad named chief medical and science officer at FDA
Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...
FDA Announces New Vouchers to Cut Drug Reviews to Two Months
The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...
MIT Technology Review5d
Here’s what food and drug regulation might look like under the Trump administration
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...